TY - JOUR
T1 - Antibiotic prescribing on admission to patients with pneumonia and prior outpatient antibiotic treatment
T2 - A cohort study on clinical outcome
AU - Van De Garde, Ewoudt M W
AU - Natsch, Stephanie
AU - Prins, Jan M.
AU - Van Der Linden, Paul D.
PY - 2015
Y1 - 2015
N2 - Objective: Most pneumonia treatment guidelines recommend that prior outpatient antibiotic treatment should be considered when planning inpatient antibiotic regimen. Our purpose was to study in patients admitted for community-acquired pneumonia the mode of continuing antibiotic treatment at the outpatient to inpatient transition and the subsequent clinical course. Design: Retrospective cohort study. Setting: Dutch PHARMO Record Linkage System. Participants: 7323 patients aged >18 years and hospitalised with pneumonia in the Netherlands between 2004 and 2010. Main study parameter: We identified all prescribed antibiotics prior to, during and after hospitalisation. In case of prior outpatient treatment, the continuation of antibiotic treatment on admission was categorised as: no atypical coverage > no atypical coverage; atypical coverage > atypical coverage; no atypical coverage > atypical coverage; and atypical coverage > no atypical coverage. Main outcome measures: Length of hospital stay, in-hospital mortality and readmission within 30 days. Results: Twenty-two per cent of the patients had received prior outpatient treatment, of which 408 (25%) patients were switched on admission to antibiotics with atypical coverage. There were no differences in length of hospital stay, in-hospital mortality or readmission rate between the four categories of patients with prior outpatient treatment. The adjusted HR for adding atypical coverage versus no atypical coverage was 0.91 (95% CI 0.55 to 1.51) for time to discharge. For in-hospital mortality and readmission within 30 days, the adjusted ORs were 1.09 (95% CI 0.85 to 1.34) and 0.59 (95% CI 0.30 to 1.18), respectively. Conclusions: This study found no association between mode of continuing antibiotic treatment at the outpatient to inpatient transition and relevant clinical outcomes. In particular, adding atypical coverage in patients without prior atypical coverage did not influence the outcome.
AB - Objective: Most pneumonia treatment guidelines recommend that prior outpatient antibiotic treatment should be considered when planning inpatient antibiotic regimen. Our purpose was to study in patients admitted for community-acquired pneumonia the mode of continuing antibiotic treatment at the outpatient to inpatient transition and the subsequent clinical course. Design: Retrospective cohort study. Setting: Dutch PHARMO Record Linkage System. Participants: 7323 patients aged >18 years and hospitalised with pneumonia in the Netherlands between 2004 and 2010. Main study parameter: We identified all prescribed antibiotics prior to, during and after hospitalisation. In case of prior outpatient treatment, the continuation of antibiotic treatment on admission was categorised as: no atypical coverage > no atypical coverage; atypical coverage > atypical coverage; no atypical coverage > atypical coverage; and atypical coverage > no atypical coverage. Main outcome measures: Length of hospital stay, in-hospital mortality and readmission within 30 days. Results: Twenty-two per cent of the patients had received prior outpatient treatment, of which 408 (25%) patients were switched on admission to antibiotics with atypical coverage. There were no differences in length of hospital stay, in-hospital mortality or readmission rate between the four categories of patients with prior outpatient treatment. The adjusted HR for adding atypical coverage versus no atypical coverage was 0.91 (95% CI 0.55 to 1.51) for time to discharge. For in-hospital mortality and readmission within 30 days, the adjusted ORs were 1.09 (95% CI 0.85 to 1.34) and 0.59 (95% CI 0.30 to 1.18), respectively. Conclusions: This study found no association between mode of continuing antibiotic treatment at the outpatient to inpatient transition and relevant clinical outcomes. In particular, adding atypical coverage in patients without prior atypical coverage did not influence the outcome.
UR - http://www.scopus.com/inward/record.url?scp=84923651040&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2014-006892
DO - 10.1136/bmjopen-2014-006892
M3 - Article
AN - SCOPUS:84923651040
SN - 2044-6055
VL - 5
JO - BMJ Open
JF - BMJ Open
IS - 2
M1 - e006892
ER -